Ovid Therapeutics, Inc. (OVID)
1.63
-0.03
(-1.81%)
USD |
NASDAQ |
Mar 03, 13:50
Ovid Therapeutics EPS Diluted (Quarterly) : -0.171 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -1.673 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.16M |
| Revenue (Quarterly) | 0.132M |
| Total Expenses (Quarterly) | 12.29M |
| Enterprise Value | 106.37M |
| Gross Profit Margin (Quarterly) | 87.12% |
| Profit Margin (Quarterly) | -9.21K% |
| Earnings Yield | -31.37% |
| Normalized Earnings Yield | -28.42 |